Free release
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine

6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine

CAS No. :1357072-61-7MDL No. :MFCD26960936Formula :C17H14N8SBoiling Point :-Linear Structure Formula :-InChI Key :JYXHZD

Sales:Service@apichina.com
CAS No. :1357072-61-7 Brand :Qitai
Formula :C17H14N8S M.W :362.41

Introduction

CAS No. :1357072-61-7 MDL No. :MFCD26960936
Formula : C17H14N8S Boiling Point : -
Linear Structure Formula :- InChI Key :JYXHZDNTBJUJNH-UHFFFAOYSA-N
M.W : 362.41 Pubchem ID :56650915
Synonyms :
Chemical Name :6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 23
Fraction Csp3 : 0.12
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 98.38
TPSA : 104.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.67
Log Po/w (XLOGP3) : 1.76
Log Po/w (WLOGP) : 2.56
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 0.79
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.65
Solubility : 0.0807 mg/ml ; 0.000223 mol/l
Class : Soluble
Log S (Ali) : -3.56
Solubility : 0.0994 mg/ml ; 0.000274 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.91
Solubility : 0.00443 mg/ml ; 0.0000122 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.05
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: